Keywords: basilea, loss, up, trial, costs, swiss, drug

Basilea's 2007 loss up 55% on trial costs

Article | 18 February 2008

Print This

Swiss drug developer Basilea Pharmaceutica says that a significant increase in its R&D spend, up 39.7% to 115.7 million Swiss francs ($104.8 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in